Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation multiples. Click to read why PFE is a Buy.
Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback